Strategies to convert to resectability the initially unresectable colorectal liver metastases

Hepato-Gastroenterology

Volumn 56, Issue 91-92, 2009, Pages 739-744

  Popescu, Irinel ^a   Alexandrescu, Sorin ^a   Croitoru, Adina ^a   Boros, Mirela ^a  

^a FUNDENI CLINICAL INSTITUTE   (Romania)

Author keywords

Colorectal liver metastases; Conversion to resectability; Portal vein ligation; Unresectable

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ARTICLE; CLINICAL ARTICLE; COLORECTAL DISEASE; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; MALE; MORBIDITY; MORTALITY; PORTAL VEIN; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; VEIN LIGATION;

ANTINEOPLASTIC AGENTS; COHORT STUDIES; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOADJUVANT THERAPY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 67651216397     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al: Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 240(4):644-657. (Pubitemid 39281287)
2. Koshariya M, Jagad RB, Kawamoto J, Papastratis P, Kefalourous H, Porfiris T, et al: An update and our experience with metastatic liver disease. Hepatogastroenterology 2007; 54(80):2232-2239.
3. Popescu I, David L, Brasoveanu V, Boros M, Hrehoret D: Two-stage hepatectomy: an analysis of a single center's experience. Magy Seb 2006; 59(3):184-189.
4. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al: Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26(5):1176-1181. (Pubitemid 27509300)
5. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, et al: Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 2008; 247(1):49-57.
6. de Baere T, Roche A, Elias D, Lasser P, Lagrange C, Bousson V: Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology 1996; 24(6):1386-1391. (Pubitemid 26399035)
7. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S: Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 1986; 10(5):803-808.
8. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, et al: Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107(5):521-527. (Pubitemid 20156653)
9. Wilms C, Mueller L, Lenk C, Wittkugel O, Helmke K, Krupski-Berdien G, et al: Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg 2008; 247(5):825-834. (Pubitemid 351591518)
10. Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N, et al: Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 2008; 12(2):297-303.
11. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, et al: Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000; 231(4):480-486. (Pubitemid 30185853)
12. Nagino M, Kamiya J, Kanai M, Uesaka K, Sano T, Yamamoto H, et al: Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery 2000; 127(2):155-160. (Pubitemid 30091261)
13. Capussotti L, Muratore A, Ferrero A, Anselmetti GC, Corgnier A, Regge D: Extension of right portal vein embolization to segment IV portal branches. Arch Surg 2005; 140(11):1100-1103. (Pubitemid 41668680)
14. Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, et al: Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000; 127(5):512-519.
15. Jaeck D, Bachellier P, Weber JC, Oussoultzoglou E, Greget M: [Process in surgical exeresis of colorectal cancer liver metastases]. Bull Acad Natl Med 2003; 187(5):863-876.
16. Elias D, Ouellet JF, de Baere T, Lasser P, Roche A: Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. Surgery 2002; 131(3):294-299. (Pubitemid 34229782)
17. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H: Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 2000; 232(6):777-785.
18. Lygidakis NJ, Singh G, Bardaxoglou E, Dedemadi G, Sgourakis G, Nestoridis J, et al: Two-stage liver surgery for advanced liver metastasis synchronous with colorectal tumor. Hepatogastroenterology 2004; 51(56):413-418. (Pubitemid 38445286)
19. Lygidakis NJ, Bhagat AD, Vrachnos P, Grigorakos L: Challenges in everyday surgical practice: synchronous bilobar hepatic colorectal metastases - newer multimodality approach. Hepatogastroenterology 2007; 54(76):1020-1024. (Pubitemid 47013896)
20. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D et al: Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996; 224(4):509-520. (Pubitemid 26337559)
21. Benoist S, Brouquet A, Penna C, Julie C, El Hajjam M, Chagnon S, et al: Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 2006; 24(24):3939-3945.
22. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, et al: Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004; 240(6):1052-1061.
23. Scappaticci FA, Fehrenbacher L, Cartwright T, Hainsworth JD, Heim W, Berlin J, et al: Surgical wound healing amplications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol 2005; 91(3):173-180. (Pubitemid 41254420)
24. D'Angelica M, Kornprat P, Gonen M, Chung KY, Jarnagin WR, DeMatteo RP, et al: Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study. Ann Surg Oncol 2007; 14(2):759-765. (Pubitemid 46175324)
25. Pozzo C, Basso M, Cassano A, Quirino M, Schinzari G, Trigila N, et al: Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 2004; 15(6):933-939. (Pubitemid 39004350)
26. Falcone A, Masi G, Allegrini G, Danesi R, Pfanner E, Brunetti IM, et al: Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer. J Clin Oncol 2002; 20(19):4006-4014.
27. Seium Y, Stupp R, Ruhstaller T, Gervaz P, Mentha G, Philippe M, et al: Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study. Ann Oncol 2005; 16(5):762-766. (Pubitemid 40767097)
28. Zelek L, Bugat R, Cherqui D, Ganem G, Valleur P, Guimbaud R, et al: Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial). Ann Oncol 2003; 14(10):1537-1542. (Pubitemid 37304610)
29. Folprecht G, Grothey A, Alberts S, Raab HR, Kohne CH: Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005; 16(8):1311-1319. (Pubitemid 41158476)
30. Popescu I, Ionescu M, Alexandrescu S, Ciurea S, Hrehoret D, Sarbu-Boeti P, et al: [Surgical treatment of liver metastases from colorectal cancer]. Chirurgia (Bucur) 2006; 101(1):13-24.
31. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B, et al: Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243(1):1-7. (Pubitemid 43054046)
32. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al: Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24(13):2065-2072. (Pubitemid 46622116)
33. Elias D, Goharin A, El Otmany A, Taieb J, Duvillard P, Lasser P, et al: Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomy. Eur J Surg Oncol 2000; 26(8):763-769. (Pubitemid 32059834)
34. Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA: Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003; 10(9):1059-1069. (Pubitemid 40486830)
35. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239(6):818-825. (Pubitemid 38669432)